A sensor and smartphone app from Israel’s 2breath helps users fall asleep and tracks their sleeping patterns; Intel has inaugurated its $6 billion next-generation chip production line at its Kiryat Gat facility in Israel, and much more.

Israel’s Eximo has successfully completed a clinical trial of its laser system and unique catheters for treating peripheral artery disease, and after 100% successful Mexican and European trials a prostate cancer drug has now been approved by Israel’s Ministry of Health.